What impact has the reform policy of pharmaceutical industry had on enterprises in recent years?

What are the published medical price policies? The following will list the medical reform policies that have brought great influence to the industry in 20 16 years.

20 16 key points of health and family planning work

Fully implement centralized drug procurement in public hospitals, encourage and guide cross-regional joint procurement, and effectively reduce false high drug prices. Raise national drug prices, negotiate drug varieties, and reduce the prices of patented drugs and exclusive drugs.

Vigorously promote the construction of graded diagnosis and treatment system. Pilot graded diagnosis and treatment in about 70% cities; The pilot provinces of medical reform and the pilot cities of public hospital reform should make every effort to promote it.

We will intensify the reform of medical insurance payment methods, implement compound payment methods such as diseases, per capita, service units and disease diagnosis related groups, and control the unreasonable growth of medical expenses. Raise the per capita financial subsidy standard of basic medical insurance for urban and rural residents; Encourage commercial insurance institutions to participate in handling services; Formulate policies and measures for the reform of medical insurance payment methods.

Outline of "Healthy China 2030"

Further deepen the reform of the medical and health system and establish and improve the basic medical and health system covering urban and rural areas. Deepen the reform of public hospitals, improve the national basic medical insurance system, reform the drug supply security system, and pay more attention to the linkage reform of medical care, medical insurance and medicine.

By 2030, everyone will enjoy all-round and life-cycle health services, the average life expectancy will reach 79 years, and the main health indicators will rank among the high-income countries.

The General Office of the State Council issued the Guiding Opinions on Promoting the Healthy Development of the Pharmaceutical Industry.

The pharmaceutical industry is an important foundation to support the development of medical and health undertakings. It is necessary to optimize the application environment, strengthen the support of factors, adjust the industrial structure, strictly supervise the industry, deepen open cooperation, stimulate the vitality of industrial innovation, reduce the cost of pharmaceutical products from R&D to listing, accelerate the reform of institutional mechanisms in the fields of approval, production, circulation and use of pharmaceutical products, promote the intelligence, service and ecology of the industry, realize the medium and high-speed development of the industry and the transformation to the middle and high-end to continuously meet the needs of the people.

The?thirteenth?Five-Year Plan

Deepen the reform of the medical and health system, adhere to the policy of putting prevention first, establish and improve the basic medical and health system, realize that everyone enjoys basic medical and health services, promote national fitness and improve people's health level.

Improve the mechanism of stable and sustainable financing and reimbursement ratio adjustment of medical insurance, and improve the medical insurance payment policy. We will fully implement the serious illness insurance system for urban and rural residents, and improve the rescue system for serious and serious diseases and the emergency rescue system for diseases. Reduce medical expenses for serious and chronic diseases. Reform medical insurance management and payment methods, reasonably control medical expenses, and realize the sustainable balance of medical insurance funds. Improve personal accounts and implement outpatient expenses as a whole. The participation rate of urban and rural medical insurance is stable at over 95%.

The General Office of the State Council issued the Notice on Deepening the Key Work of Medical and Health System Reform in 20 16 years.

The pilot provinces of medical reform should promote the two-vote system in the whole range and encourage the one-vote system. Hospitals and pharmaceutical production enterprises directly settle the payment for goods, and pharmaceutical companies and distribution enterprises calculate the distribution costs. Four pilot provinces for medical reform were added this year. The previous four provinces brought the number of pilot provinces for medical reform nationwide to eight, namely Anhui, Fujian, Jiangsu, Qinghai, Shaanxi, Shanghai, Zhejiang and Sichuan. These eight provinces have decided to promote the two-vote system.

Take various forms to promote the separation of medicines, prohibit hospitals from restricting the outflow of prescriptions, and patients can choose to buy medicines in hospital outpatient pharmacies or retail pharmacies with prescriptions.

The National Development and Reform Commission issued the Notice on Carrying out Special Inspection of Drug Prices in China.

From June 1 day, a special inspection of drug prices will be carried out nationwide, focusing on the raw materials and drug varieties with abnormal price fluctuations, maintaining the price order in the drug market and protecting the legitimate rights and interests of the people.

The scope of inspection covers seven platforms, including pharmaceutical production and operation enterprises, medical institutions and blood stations, and will focus on solving problems that have been complained or strongly reflected many times before. For typical cases with serious circumstances and bad nature, "it is necessary to investigate and deal with them together and expose them together to form a powerful shock."

Opinions on strengthening the reform and development of children's medical and health services

Request to adjust the price of pediatric medical services. Medical services such as invasive biopsy and exploration in children's clinical diagnosis and clinical surgical treatment are higher than adult medical services, and are included in the scope of medical insurance payment according to regulations.

Do a good job in ensuring the supply of medicines for children. Establish a special channel for the examination and approval of children's drugs, give policy support to children's drug prices, establish and improve the early warning mechanism for the supply of short drugs, and keep abreast of the production trends of short drugs for children.

Notice on Issuing the Opinions on Promoting Drug Price Reform

From June 1, the government pricing of most drugs will be cancelled, the drug procurement mechanism will be improved, and medical insurance will play a role in controlling fees. The actual transaction price of drugs is mainly formed by market competition.

Drug price violations are included in the price integrity record, and serious violations of drug production and operation enterprises are included in the bad records of centralized drug procurement according to relevant regulations. After the drug price reform, the competent pricing department will severely crack down on unfair price behaviors and price monopoly behaviors such as 10 kinds of high-priced drugs according to relevant laws and regulations.

Guiding opinions on actively promoting the linkage reform of medical care, medical insurance and medicine

Taking controlling the unreasonable growth of medical expenses as an important part of the comprehensive reform of public hospitals, we will promote the establishment of a mechanism to control the excessive growth of medical expenses and effectively improve the people's sense of gain.

Put the reform of payment method in the prominent position of medical reform. Combined with the budget management of medical insurance fund, we will comprehensively promote the total payment control, accelerate the payment by disease and per head, actively promote the application of DRGs, explore the combination of total payment control and integral method, and establish a composite payment method.

Formulate medical insurance payment standards for drugs and medical services that are compatible with price reform, explore the establishment of a mechanism to guide the rational formation of drug prices, and promote medical institutions to actively reduce purchase prices; It is necessary to explore the establishment of a new mechanism for medical insurance drug access and inquiry, and give play to the guiding and regulating role of medical insurance in the allocation of medical resources; It is necessary to promote the reform of the drug circulation system, promote the separation of medicine from medicine, explore the separate payment of medical services and drugs, and eliminate the stubborn disease of public hospitals supporting medicine from the institutional mechanism.

20 16 national work plan for adjusting the drug list of basic medical insurance, industrial injury insurance and maternity insurance (draft for comment) further optimizes the directory structure, appropriately expands the scope of the directory, supports and encourages medical innovation, gradually improves the level of protection, and effectively guarantees the drug demand of the majority of insured persons and the safe and stable operation of the medical insurance fund. We will adhere to the guidance of clinical needs, pay equal attention to both Chinese and western medicine, and the number of western medicine and Chinese patent medicine (including ethnic medicine) will basically increase in a balanced way.

Drug list adjustment is divided into drug transfer-in and drug transfer-out. The adjustment is based on the registration data of the US Food and Drug Administration, and it does not accept the declaration or recommendation of enterprises, and does not charge fees such as review fees.

Key tasks of deepening the reform of medical and health system 20 16